Single agent BMS-911543 Jak2 inhibitor has distinct inhibitory effects on STAT5 signaling in genetically engineered mice with pancreatic cancer

類似資料

• BMS-911543 inhibits viability of tumor and stromal cells and limits disease progression in genetically engineered mice with pancreatic cancer
  著者:: Mace, Thomas, 等
  出版事項: (2014)
• Anti-IL-6 and PD-L1 antibody combination therapy reduces tumor progression in murine models of pancreatic cancer
  著者:: Mace, Thomas, 等
  出版事項: (2015)
• Genetically engineered murine pancreatic cancer models approximate immunophenotypic properties of human patients
  著者:: Mace, Thomas A, 等
  出版事項: (2013)
• Cholangiocarcinoma cells secrete soluble factors that activate Jak/STAT signal transduction and promote MDSC expansion
  著者:: Yang, Jennifer, 等
  出版事項: (2014)
• Discovery of a Highly Selective JAK2 Inhibitor, BMS-911543, for the Treatment of Myeloproliferative Neoplasms
  著者:: Wan, Honghe, 等
  出版事項: (2015)